Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes
US10668062B2 · kind B2 · utility
5Cited by
13References
20Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 30, 2018 |
| Grant date | Jun 2, 2020 |
| Priority date | — |
| Expiry date | Nov 30, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of increasing the insulin sensitivity of a mammalian cell by contacting the cell with a protein phosphatase 2A (PP2A) inhibitor having the structure (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.